HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Monique Nilsson Selected Research
Monique Nilsson Research Topics
Disease
9
Neoplasms (Cancer)
07/2022 - 07/2006
6
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 07/2006
2
Adenocarcinoma of Lung
07/2022 - 01/2021
1
Glioblastoma (Glioblastoma Multiforme)
11/2021
1
Hypoxia (Hypoxemia)
01/2021
1
Lung Neoplasms (Lung Cancer)
01/2021
1
Squamous Cell Carcinoma of Head and Neck
01/2021
1
Carcinogenesis
01/2021
1
Neoplasm Metastasis (Metastasis)
11/2020
1
Malignant Mesothelioma
01/2018
1
Neuroblastoma
02/2008
Drug/Important Bio-Agent (IBA)
5
Tyrosine Kinase Inhibitors
IBA
07/2022 - 02/2008
3
ErbB Receptors (EGF Receptor)
IBA
07/2016 - 07/2006
2
Bevacizumab (Avastin)
FDA Link
07/2022 - 02/2008
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2021 - 02/2008
2
Biomarkers (Surrogate Marker)
IBA
01/2018 - 05/2014
2
vandetanib (ZD6474)
IBA
02/2008 - 07/2006
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
02/2008 - 07/2006
1
N 30
IBA
07/2022
1
NADP (NADPH)
IBA
01/2022
1
Adenosine Triphosphate (ATP)
IBA
01/2022
1
Nucleosides
IBA
01/2022
1
Nucleotides
IBA
01/2022
1
Protein Isoforms (Isoforms)
IBA
11/2021
1
Carcinogens
IBA
01/2021
1
Immune Checkpoint Inhibitors
IBA
01/2021
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2021
1
Adenosine (Adenocard)
FDA Link
Generic
01/2021
1
B7-H1 Antigen
IBA
01/2021
1
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
11/2020
1
osimertinib
IBA
11/2020
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
03/2018
1
Dasatinib (BMS 354825)
FDA Link
01/2018
1
HhAntag691
IBA
11/2017
1
Polo-Like Kinase 1
IBA
07/2016
1
Antigens
IBA
05/2014
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
02/2008
1
Monoclonal Antibodies
IBA
02/2008
1
Mitogen-Activated Protein Kinases
IBA
02/2008
1
Proto-Oncogene Proteins c-ret
IBA
02/2008
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
02/2008
1
Cetuximab (Erbitux)
FDA Link
07/2006
1
Gefitinib (Iressa)
FDA Link
07/2006
Therapy/Procedure
2
Therapeutics
11/2021 - 01/2021
1
Immunotherapy
07/2022
1
Drug Therapy (Chemotherapy)
07/2022
1
Aftercare (After-Treatment)
02/2008